Haemonetics: CSL expects to complete rollout of NexSys PCS devices by end of 2027

HAEMONETICS CORP

CSL Plasma Inc. expects to complete rollout of Haemonetics' NexSys PCS devices with Persona PLUS technology and related disposables by end of calendar year 2027.
CSL currently anticipates the transition to Haemonetics devices and disposables will occur at all of CSL's current U.S. plasma collection centers.
Haemonetics is not updating its previously issued fiscal 2027 guidance at this time.
Haemonetics expects to update the supply agreement's anticipated impact on fiscal 2027 results during its second fiscal quarter earnings call in November 2026.
Scope and timing of the rollout remain subject to change, and implementation details are still to be determined by CSL and Haemonetics.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.